Skip to main content
Premium Trial:

Request an Annual Quote

BioTrove and Schering-Plough Expand Drug-Discovery Collaboration

NEW YORK, Dec. 6 (GenomeWeb News) - BioTrove has expanded its lead discovery collaboration with Schering-Plough Research Institute, the research arm of Schering-Plough, the company said today.

 

Under the terms of the collaboration, BioTrove will use its RapidFire lead-discovery service for assay development and high-throughput screening on an undisclosed number of targets identified by Schering-Plough.

 

RapidFire is a mass spectrometry-based technology that enables the high-throughput screening of biochemical assays, BioTrove said. The use of mass spectrometry allows for label-free screening of challenging and intractable drug targets using native substrates, the company said.

 

Financial terms were not disclosed.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.